Software developer SunGard said independent valuation of over-the-counter derivatives will become more important with the ratification of UCITS IV. Paul Compton, head of product management in alternative investments at SunGard an author of white paper released this week, said, one of the benefits of “true independent valuations” is “the reassurance to clients that each contract is being accurately valued.”

Click here to read the story from Hedge Week